Cargando…

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice

OBJECTIVE: Interferon regulatory factor (IRF) 5 is a transcription factor known for promoting M1 type macrophage polarization in vitro. Given the central role of inflammatory macrophages in promoting atherosclerotic plaque progression, we hypothesize that myeloid cell-specific deletion of IRF5 is pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Leipner, Julia, Dederichs, Tsai-Sang, von Ehr, Alexander, Rauterberg, Simon, Ehlert, Carolin, Merz, Julian, Dufner, Bianca, Hoppe, Natalie, Krebs, Katja, Heidt, Timo, von zur Muehlen, Constantin, Stachon, Peter, Ley, Klaus, Wolf, Dennis, Zirlik, Andreas, Bode, Christoph, Hilgendorf, Ingo, Härdtner, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178123/
https://www.ncbi.nlm.nih.gov/pubmed/33991749
http://dx.doi.org/10.1016/j.molmet.2021.101250
_version_ 1783703524068032512
author Leipner, Julia
Dederichs, Tsai-Sang
von Ehr, Alexander
Rauterberg, Simon
Ehlert, Carolin
Merz, Julian
Dufner, Bianca
Hoppe, Natalie
Krebs, Katja
Heidt, Timo
von zur Muehlen, Constantin
Stachon, Peter
Ley, Klaus
Wolf, Dennis
Zirlik, Andreas
Bode, Christoph
Hilgendorf, Ingo
Härdtner, Carmen
author_facet Leipner, Julia
Dederichs, Tsai-Sang
von Ehr, Alexander
Rauterberg, Simon
Ehlert, Carolin
Merz, Julian
Dufner, Bianca
Hoppe, Natalie
Krebs, Katja
Heidt, Timo
von zur Muehlen, Constantin
Stachon, Peter
Ley, Klaus
Wolf, Dennis
Zirlik, Andreas
Bode, Christoph
Hilgendorf, Ingo
Härdtner, Carmen
author_sort Leipner, Julia
collection PubMed
description OBJECTIVE: Interferon regulatory factor (IRF) 5 is a transcription factor known for promoting M1 type macrophage polarization in vitro. Given the central role of inflammatory macrophages in promoting atherosclerotic plaque progression, we hypothesize that myeloid cell-specific deletion of IRF5 is protective against atherosclerosis. METHODS: Female Apoe(–/–)Lysm(Cre/+)Irf5(fl/fl) and Apoe(−/−)Irf5(fl/fl) mice were fed a high-cholesterol diet for three months. Atherosclerotic plaque size and compositions as well as inflammatory gene expression were analyzed. Mechanistically, IRF5-dependent bone marrow-derived macrophage cytokine profiles were tested under M1 and M2 polarizing conditions. Mixed bone marrow chimeras were generated to determine intrinsic IRF5-dependent effects on macrophage accumulation in atherosclerotic plaques. RESULTS: Myeloid cell-specific Irf5 deficiency blunted LPS/IFNγ-induced inflammatory gene expression in vitro and in the atherosclerotic aorta in vivo. While atherosclerotic lesion size was not reduced in myeloid cell-specific Irf5-deficient Apoe(–/–) mice, plaque composition was favorably altered, resembling a stable plaque phenotype with reduced macrophage and lipid contents, reduced inflammatory gene expression and increased collagen deposition alongside elevated Mertk and Tgfβ expression. Irf5-deficient macrophages, when directly competing with wild type macrophages in the same mouse, were less prone to accumulate in atherosclerotic lesion, independent of monocyte recruitment. Irf5-deficient monocytes, when exposed to oxidized low density lipoprotein, were less likely to differentiate into macrophage foam cells, and Irf5-deficient macrophages proliferated less in the plaque. CONCLUSION: Our study provides genetic evidence that selectively altering macrophage polarization induces a stable plaque phenotype in mice.
format Online
Article
Text
id pubmed-8178123
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81781232021-06-15 Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice Leipner, Julia Dederichs, Tsai-Sang von Ehr, Alexander Rauterberg, Simon Ehlert, Carolin Merz, Julian Dufner, Bianca Hoppe, Natalie Krebs, Katja Heidt, Timo von zur Muehlen, Constantin Stachon, Peter Ley, Klaus Wolf, Dennis Zirlik, Andreas Bode, Christoph Hilgendorf, Ingo Härdtner, Carmen Mol Metab Original Article OBJECTIVE: Interferon regulatory factor (IRF) 5 is a transcription factor known for promoting M1 type macrophage polarization in vitro. Given the central role of inflammatory macrophages in promoting atherosclerotic plaque progression, we hypothesize that myeloid cell-specific deletion of IRF5 is protective against atherosclerosis. METHODS: Female Apoe(–/–)Lysm(Cre/+)Irf5(fl/fl) and Apoe(−/−)Irf5(fl/fl) mice were fed a high-cholesterol diet for three months. Atherosclerotic plaque size and compositions as well as inflammatory gene expression were analyzed. Mechanistically, IRF5-dependent bone marrow-derived macrophage cytokine profiles were tested under M1 and M2 polarizing conditions. Mixed bone marrow chimeras were generated to determine intrinsic IRF5-dependent effects on macrophage accumulation in atherosclerotic plaques. RESULTS: Myeloid cell-specific Irf5 deficiency blunted LPS/IFNγ-induced inflammatory gene expression in vitro and in the atherosclerotic aorta in vivo. While atherosclerotic lesion size was not reduced in myeloid cell-specific Irf5-deficient Apoe(–/–) mice, plaque composition was favorably altered, resembling a stable plaque phenotype with reduced macrophage and lipid contents, reduced inflammatory gene expression and increased collagen deposition alongside elevated Mertk and Tgfβ expression. Irf5-deficient macrophages, when directly competing with wild type macrophages in the same mouse, were less prone to accumulate in atherosclerotic lesion, independent of monocyte recruitment. Irf5-deficient monocytes, when exposed to oxidized low density lipoprotein, were less likely to differentiate into macrophage foam cells, and Irf5-deficient macrophages proliferated less in the plaque. CONCLUSION: Our study provides genetic evidence that selectively altering macrophage polarization induces a stable plaque phenotype in mice. Elsevier 2021-05-12 /pmc/articles/PMC8178123/ /pubmed/33991749 http://dx.doi.org/10.1016/j.molmet.2021.101250 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Leipner, Julia
Dederichs, Tsai-Sang
von Ehr, Alexander
Rauterberg, Simon
Ehlert, Carolin
Merz, Julian
Dufner, Bianca
Hoppe, Natalie
Krebs, Katja
Heidt, Timo
von zur Muehlen, Constantin
Stachon, Peter
Ley, Klaus
Wolf, Dennis
Zirlik, Andreas
Bode, Christoph
Hilgendorf, Ingo
Härdtner, Carmen
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
title Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
title_full Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
title_fullStr Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
title_full_unstemmed Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
title_short Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
title_sort myeloid cell-specific irf5 deficiency stabilizes atherosclerotic plaques in apoe(–/–) mice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178123/
https://www.ncbi.nlm.nih.gov/pubmed/33991749
http://dx.doi.org/10.1016/j.molmet.2021.101250
work_keys_str_mv AT leipnerjulia myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT dederichstsaisang myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT vonehralexander myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT rauterbergsimon myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT ehlertcarolin myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT merzjulian myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT dufnerbianca myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT hoppenatalie myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT krebskatja myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT heidttimo myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT vonzurmuehlenconstantin myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT stachonpeter myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT leyklaus myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT wolfdennis myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT zirlikandreas myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT bodechristoph myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT hilgendorfingo myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice
AT hardtnercarmen myeloidcellspecificirf5deficiencystabilizesatheroscleroticplaquesinapoemice